Orally administered factor xa inhibitor, rivaroxaban: A novel thromboembolic prophylaxis agent

Ricardo J. Komotar, Robert M. Starke, E. Sander Connolly

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Orally administered factor xa inhibitor, rivaroxaban: A novel thromboembolic prophylaxis agent'. Together they form a unique fingerprint.